<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T00:51:51Z</responseDate>
  <request identifier="oai:figshare.com:article/33979471" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33979471</identifier>
        <datestamp>2026-09-24T04:33:34Z</datestamp>
        <setSpec>category_19</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Hepatoprotective action of Dendrobium officinale polysaccharide against MAFLD: modulation of gut microbiota-metabolite cascade controls TLR4/NF-κB inflammatory response.pdf</dc:title>
          <dc:creator>Yumei Xu (8293980)</dc:creator>
          <dc:creator>Yanmei Zhang (122913)</dc:creator>
          <dc:creator>Shuqing Li (1430998)</dc:creator>
          <dc:creator>Heyan Yao (16942366)</dc:creator>
          <dc:creator>Yang Yang (45629)</dc:creator>
          <dc:creator>Cuiping Yu (841336)</dc:creator>
          <dc:creator>Shunzhen Zhang (169138)</dc:creator>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Dendrobium officinale polysaccharide</dc:subject>
          <dc:subject>intestinal microflora-derived metabolites</dc:subject>
          <dc:subject>lipopolysaccharide</dc:subject>
          <dc:subject>medicinal and edible homologous plant</dc:subject>
          <dc:subject>metabolic dysfunction-associated fatty liver disease</dc:subject>
          <dc:subject>TLR4/NF-κB inflammatory pathway</dc:subject>
          <dc:description>Introduction&lt;p&gt;Metabolic dysfunction-associated fatty liver disease (MAFLD) threatens public health worldwide, and Dendrobium officinale polysaccharide (DOP) exhibits promising hepatoprotective potential, yet its regulatory mechanism targeting the gut microbiota-metabolite-TLR4/NF-κB inflammatory axis remains poorly defined.&lt;/p&gt;Methods&lt;p&gt;In this study, in-vivo rat and in-vitro HepG2 cell MAFLD models were established. Male Sprague-Dawley (SD) rats received 12-week high-fat diet (HFD) feeding to induce MAFLD; HepG2 cells were exposed to a 1 mmol/L free fatty acid (FFA) mixture (oleic acid/palmitic acid = 2:1) for 24 h to trigger cellular steatosis. Serum, hepatic and cellular biochemical indexes, intestinal permeability factors and inflammatory mediators were detected. Hepatic pathological lesions and lipid accumulation were evaluated via hematoxylin-eosin (HE) and Oil Red O staining. Fecal metagenomics and untargeted metabolomics were applied to profile gut microbes and differential metabolites. RT-qPCR and Western blotting were used to assess tight-junction protein expression and TLR4/NF-κB pathway activation.&lt;/p&gt;Results&lt;p&gt;DOP markedly alleviated hepatic lipid accumulation, restored liver function abnormalities and mitigated hepatic pathological damage. DOP reshaped the disturbed gut flora: it reduced lipopolysaccharide (LPS)-enriched Gram-negative bacteria, elevated short-chain fatty acid-producing probiotics, modified intestinal metabolites, repaired the intestinal barrier and prevented intestinal LPS leakage. Both cellular and animal experiments demonstrated that DOP down-regulated TLR4, MyD88 and NF-κB p65 levels, increased IκBα expression and suppressed downstream pro-inflammatory mediators.&lt;/p&gt;Discussion&lt;p&gt;Collectively, DOP confers protective effects against MAFLD through remodeling gut microbiota and intestinal metabolites, preserving intestinal-barrier integrity, and inhibiting LPS-provoked hepatic TLR4/NF-κB inflammatory activation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-24T04:33:34Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fphar.2026.1953606.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Hepatoprotective_action_of_Dendrobium_officinale_polysaccharide_against_MAFLD_modulation_of_gut_microbiota-metabolite_cascade_controls_TLR4_NF-_B_inflammatory_response_pdf/33979471</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
